Research

Tooth survival and outcomes 26 years after guided tissue regeneration

11.05.20

Periodontal disease, affecting hundreds of millions adults globally, is a leading cause of tooth loss and negatively impacts oral health-related quality of life.

Impact of non-surgical periodontal therapy on cardiac function in type 2 diabetes

29.04.20

Inflammation plays a pivotal role in cardiovascular disease (CVD) progression, particularly in patients with diabetes mellitus (DM) and periodontitis, which share risk factors and systemic inflammatory pathways.

Periodontitis treatment lowers systemic inflammation in type 2 diabetes

27.02.20

Periodontitis, affecting 11.2% globally, causes tissue destruction, tooth loss, and reduced quality of life. Its bidirectional link with type 2 diabetes mellitus (T2DM) is well-established, with diabetes increasing periodontitis risk and periodontitis worsening glycemic control.

Impact of risk factor control in patients with periodontitis

07.01.20

Periodontitis progression is influenced by common risk factors, including poor oral hygiene, smoking, and lifestyle habits. Interventions targeting these factors can improve treatment outcomes and periodontal health.

Identifying key risk factors for tooth loss in periodontitis

26.04.19

• Diabetes mellitus (DM) is associated with severe systemic and oral health complications, including periodontitis, which is characterised by gum inflammation, periodontal tissue damage, and tooth loss.
• Pre-diabetes, a metabolic condition with elevated blood glucose levels below the diabetic threshold, is also linked to complications like nephropathy and neuropathy.

Periodontitis as a risk factor of chronic kidney disease

16.04.19

Chronic kidney disease (CKD) involves impaired kidney function, increasing the risk of cardiovascular disease, infection, and mortality. Despite medical advances, CKD prevalence is rising globally.

The impact of diabetes on short-term periodontal treatment outcomes

20.01.19

Periodontitis and diabetes mellitus (DM) are closely linked, with DM being a significant risk factor for severe periodontitis. Conversely, periodontitis may exacerbate glycaemic management in people living wiith diabetes.
Non-surgical periodontal therapy is an effective treatment to reduce inflammation and improve periodontal health. However, there is uncertainty regarding how diabetes impacts the clinical response to periodontal treatment.

Impact of periodontitis treatment on type 2 diabetes

24.10.18

The global rise in type 2 diabetes is a significant contributor to disability and early mortality, often due to vascular and renal complications. Chronic inflammation affects glycaemic control in diabetes, linking it with cardiovascular and kidney diseases. Periodontitis, a prevalent inflammatory condition often co-existing with diabetes, involves an imbalance in oral bacteria and elicits a systemic inflammatory response, raising risks for severe conditions like cardiovascular disease and renal failure. Periodontal therapy aims to manage inflammation through dental cleaning, oral hygiene advice, and possible surgical intervention.

Effects of scaling and root planing and antibiotics in patients with periodontitis +/- diabetes

21.10.18

• Diabetes mellitus (DM) and periodontitis are chronic conditions that may adversely affect each other.
• Patients with diabetes generally show delayed healing and higher susceptibility to infections, influencing periodontal treatment outcomes.

Periodontal treatment and its effect on diabetes outcomes

14.09.18

Diabetes mellitus (DM) is closely associated with periodontitis, with evidence suggesting a bidirectional relationship. While periodontitis may exacerbate systemic inflammation and insulin resistance, periodontal therapy is hypothesised to improve glycaemic management and reduce inflammation in people living with diabetes.

Tooth survival and outcomes 26 years after guided tissue regeneration

11.05.20

Periodontal disease, affecting hundreds of millions adults globally, is a leading cause of tooth loss and negatively impacts oral health-related quality of life.

Impact of non-surgical periodontal therapy on cardiac function in type 2 diabetes

29.04.20

Inflammation plays a pivotal role in cardiovascular disease (CVD) progression, particularly in patients with diabetes mellitus (DM) and periodontitis, which share risk factors and systemic inflammatory pathways.

Periodontitis treatment lowers systemic inflammation in type 2 diabetes

27.02.20

Periodontitis, affecting 11.2% globally, causes tissue destruction, tooth loss, and reduced quality of life. Its bidirectional link with type 2 diabetes mellitus (T2DM) is well-established, with diabetes increasing periodontitis risk and periodontitis worsening glycemic control.

Impact of risk factor control in patients with periodontitis

07.01.20

Periodontitis progression is influenced by common risk factors, including poor oral hygiene, smoking, and lifestyle habits. Interventions targeting these factors can improve treatment outcomes and periodontal health.

Identifying key risk factors for tooth loss in periodontitis

26.04.19

• Diabetes mellitus (DM) is associated with severe systemic and oral health complications, including periodontitis, which is characterised by gum inflammation, periodontal tissue damage, and tooth loss.
• Pre-diabetes, a metabolic condition with elevated blood glucose levels below the diabetic threshold, is also linked to complications like nephropathy and neuropathy.

Periodontitis as a risk factor of chronic kidney disease

16.04.19

Chronic kidney disease (CKD) involves impaired kidney function, increasing the risk of cardiovascular disease, infection, and mortality. Despite medical advances, CKD prevalence is rising globally.

The impact of diabetes on short-term periodontal treatment outcomes

20.01.19

Periodontitis and diabetes mellitus (DM) are closely linked, with DM being a significant risk factor for severe periodontitis. Conversely, periodontitis may exacerbate glycaemic management in people living wiith diabetes.
Non-surgical periodontal therapy is an effective treatment to reduce inflammation and improve periodontal health. However, there is uncertainty regarding how diabetes impacts the clinical response to periodontal treatment.

Impact of periodontitis treatment on type 2 diabetes

24.10.18

The global rise in type 2 diabetes is a significant contributor to disability and early mortality, often due to vascular and renal complications. Chronic inflammation affects glycaemic control in diabetes, linking it with cardiovascular and kidney diseases. Periodontitis, a prevalent inflammatory condition often co-existing with diabetes, involves an imbalance in oral bacteria and elicits a systemic inflammatory response, raising risks for severe conditions like cardiovascular disease and renal failure. Periodontal therapy aims to manage inflammation through dental cleaning, oral hygiene advice, and possible surgical intervention.

Effects of scaling and root planing and antibiotics in patients with periodontitis +/- diabetes

21.10.18

• Diabetes mellitus (DM) and periodontitis are chronic conditions that may adversely affect each other.
• Patients with diabetes generally show delayed healing and higher susceptibility to infections, influencing periodontal treatment outcomes.

Periodontal treatment and its effect on diabetes outcomes

14.09.18

Diabetes mellitus (DM) is closely associated with periodontitis, with evidence suggesting a bidirectional relationship. While periodontitis may exacerbate systemic inflammation and insulin resistance, periodontal therapy is hypothesised to improve glycaemic management and reduce inflammation in people living with diabetes.